Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Zimmer Biomet Holdings Inc (NYSE:ZBH)

122.35
Delayed Data
As of Oct 20
 +0.47 / +0.39%
Today’s Change
95.63
Today|||52-Week Range
133.49
+18.56%
Year-to-Date
NuVasive's TLX Interbody System Gets Expanded FDA Approval
Oct 19 / Zacks.com - Paid Partner Content
Smith & Nephew: hippy hippy shake-up
Oct 11 / FT.com - Paid Partner Content

Today’s Trading

Previous close121.88
Today’s open122.37
Day’s range121.32 - 122.83
Volume792,749
Average volume (3 months)1,351,807
Market cap$24.7B
Dividend yield0.78%
Data as of 4:01pm ET, 10/20/2017

Growth & Valuation

Earnings growth (last year)+96.10%
Earnings growth (this year)+3.52%
Earnings growth (next 5 years)+9.00%
Revenue growth (last year)+28.11%
P/E ratio34.9
Price/Sales2.72
Price/Book2.54

Competitors

 Today’s
change
Today’s
% change
BCRC R Bard Inc+2.86+0.87%
TFXTeleflex Inc+1.07+0.44%
BSXBoston Scientific Co...+0.12+0.41%
ABMDAbiomed Inc+2.41+1.40%
Data as of 4:03pm ET, 10/20/2017

Financials

Next reporting dateNovember 1, 2017
EPS forecast (this quarter)$1.75
Annual revenue (last year)$7.7B
Annual profit (last year)$305.9M
Net profit margin3.98%

Profile

Sector
Health Technology
Industry
Medical Specialties
Director, Chief Executive &
Financial Officer
Daniel P. Florin
Senior VP-Global Operations &
Logistics
Adrian Furey
Corporate headquarters
Warsaw, Indiana

Forecasts